Balloon-based ablation for atrial fibrillation: post-approval study
Part of Heart & circulation clinical trials.
This trial tests a balloon catheter that uses pulsed field energy to treat atrial fibrillation (AF) in people who have tried medication without success. It aims to see how well it works in real-world use.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with paroxysmal or persistent atrial fibrillation that comes and goes or lasts up to a year.
- You have tried at least one heart rhythm medication (like beta blockers or calcium channel blockers) and it didn't work well or you couldn't take it.
- You are 18 years or older and planning to have your first ablation procedure with the Volt PFA catheter.
- You do not have any serious heart or blood-related conditions, recent heart procedures, or other health issues that would make this treatment unsafe.
- You must be able to attend follow-up visits and tests over the next 12 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new way to treat atrial fibrillation using targeted electrical pulses (pulsed field ablation) instead of heat or cold. The goal is to improve safety and outcomes for people with paroxysmal or persistent AF.
This trial tests a new method called pulsed field ablation to treat atrial fibrillation (AF), a type of irregular heartbeat. It aims to safely stop AF episodes by targeting specific areas in the heart, and may help people with paroxysmal (coming and going) or persistent AF who haven't had this procedure before.
This study tests a new type of energy called pulsed field ablation to treat atrial fibrillation, an irregular heartbeat. It aims to see if it is safe and effective for people whose symptoms have not improved with medication.
This trial tests a new catheter system to treat atrial fibrillation (AF) by creating small scars in the heart to block faulty signals. It may help people with symptoms that continue despite medication and who are scheduled for a standard ablation procedure.
This study tests two types of pulsed field ablation catheters to treat persistent atrial fibrillation, a heart rhythm problem lasting more than 7 days but less than a year. The goal is to see if these catheters can safely and effectively restore a normal heart rhythm.
This trial studies a new procedure called pulsed field ablation to treat brief episodes of atrial fibrillation (AFib). The goal is to see if it can help reset the heart's natural electrical system and reduce symptoms.
Hear when a new Paroxysmal AF trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.